Mylan Launches First Generic Version of Antihypertensive Sular(R) ER in the United States
PITTSBURGH, July 28 (HSMN NewsFeed) -- Mylan Inc. (NYSE: MYL ) today announced that its subsidiary, Mylan Pharmaceuticals Inc., has received final approval from the U.S. Food and Drug Administration (FDA) for its Abbreviated New Drug Application (ANDA) f... Biopharmaceuticals, Generics, FDAMylan, Nisoldipine, Sular , Sciele Pharma (Source: HSMN NewsFeed)

Robust, Durable Responses With Vedolizumab for UCRobust, Durable Responses With Vedolizumab for UC
DDW 2012: Data are considered 'fantastic' by late-breaking session moderators with the anti-TNF-alpha agent in treatment-resistant ulcerative colitis (UC). Medscape Medical News (Source: Medscape Today Headlines)div id=medwormpbiMedWorm Sponsor Message:/i/b Have a look at a href=http://www.thepsychologydaily.comThe Psychology Daily/a, the new psychology portal powered by MedWorm, with all the latest psychology news and research updated daily./p/div